Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CPT2 | P23786 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21048439 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL8604348 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL156918 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Acetic Acid SCHEMBL15573268 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL597227 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Acetone SCHEMBL9653544 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL27493653 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL28960526 | 0.98 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL9407370 | 0.96 | CYP2C19 (0.39) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Water SCHEMBL7198408 | 0.96 | CYP2C19 (0.39) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033491-A1 | FUNGAL SPORE FORMULATIONS INCLUDING CARRIER FLUIDS | BAYER AG (DE) | 2026-02-05 | — | — | US | claimed |
| US-12453698-B2 | Pharmaceutical biodissolvable gels for drug delivery | AIVIVA BIOPHARMA, INC. (US) | 2025-10-28 | — | — | US | claimed |
| EP-3786150-B1 | DETERGENTS AND CLEANING AGENTS CONTAINING HYDROXYCARBOXYLIC ACID ESTERS AND USE OF HYDROXYCARBOXYLIC ACID ESTERS | WeylChem Performance Products GmbH (DE) | 2025-07-30 | — | — | EP | claimed |
| US-20250194619-A1 | PLANT FRESHNESS KEEPING COMPOSITION, PLATE-SHAPED BODY, STACK, LABEL, AND PACKAGING MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-06-19 | — | — | US | claimed |
| EP-4534881-A1 | FLEXIBLE TUBE | Toyox Co., Ltd. (JP) | 2025-04-09 | — | — | EP | claimed |
| CN-119301395-A | Flexible pipe | 东洋克斯株式会社 | 2025-01-10 | — | — | CN | claimed |
| CN-118988017-A | Porous membrane, method for producing saccharification liquid using porous membrane, and filtration method using porous membrane | 旭化成株式会社 | 2024-11-22 | — | — | CN | claimed |
| US-12084551-B2 | Tea fiber/PHBV/PBAT ternary composite and preparation method and application thereof | ZENCE OBJECT TECHNOLOGY (SHENZHEN) CO., LTD. (CN) | 2024-09-10 | — | — | US | claimed |
| CN-118374227-A | Environment-friendly solvent asphalt emulsion and preparation method thereof | 中国建筑第六工程局有限公司 | 2024-07-23 | — | — | CN | claimed |
| EP-4380366-A1 | ARTHROPOD CONTROL PRODUCTS | Firmenich SA (CH) | 2024-06-12 | — | — | EP | claimed |
| EP-0456782-B1 | TMB FORMULATION FOR SOLUBLE AND PRECIPITABLE HRP-ELISA | BIOVEST INC (US) | 1996-01-17 | — | — | EP | claimed |
| EP-0383018-B1 | Process for impregnating tobacco smoke filter fibres with polycarboxylic acid or salts thereof | BAT CIGARETTENFAB GMBH (DE) | 1994-01-05 | — | — | EP | claimed |
| EP-0456782-A1 | TMB FORMULATION FOR SOLUBLE AND PRECIPITABLE HRP-ELISA. | TSI CORP (US) | 1991-11-21 | — | — | EP | claimed |
| WO-1991006672-A1 | TMB FORMULATION FOR SOLUBLE AND PRECIPITABLE HRP-ELISA | TSI-MASON RESEARCH INSTITUTE (US) | 1991-05-16 | — | — | WO | claimed |
| US-5013646-A | Tetramethylbenzidine, color, vinylpyrrolidone polymers and chromogen | TRANSGENIC SCIENCES, INC. (US) | 1991-05-07 | — | — | US | claimed |
| US-4950747-A | ADDING LOW MOLECULAR WEIGHT ELECTROLYTE BEFORE DRYING TO IMPROVE VISCOSITY | ALLIED COLLOIDS LTD. (GB) | 1990-08-21 | — | — | US | claimed |
| US-4777034-A | LONG-LASTING FOOT ANTIPERSPIRANT | OLIVIER GEORGES R G (FR) | 1988-10-11 | — | — | US | claimed |
| US-4583980-A | Sanitary hygiene products having odor-preventing properties | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1986-04-22 | — | — | US | claimed |
| EP-0046533-B1 | ODOUR-REDUCING SANITARY ARTICLE FOR ABSORBING BODILY WASTE FLUIDS CONTAINING URINE AND BLOOD | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-11-21 | — | — | EP | claimed |
| US-4010253-A | Process of suppressing odors employing deodorants containing esters of citric acid | HENKEL & CIE G.M.B.H. (DT) | 1977-03-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033491-A1 | FUNGAL SPORE FORMULATIONS INCLUDING CARRIER FLUIDS | ERG28, CERT1, MGLL | CYP2C19 4191/4885HIF1A 3406/4885CYP2D6 3160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.